6

60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP

Watchlist Manager
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Watchlist
Price: 0.696 USD 1.02% Market Closed
Market Cap: 2.9m USD

Wall Street
Price Targets

SXTP Price Targets Summary
60 Degrees Pharmaceuticals Inc

Wall Street analysts forecast SXTP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SXTP is 4.488 USD with a low forecast of 2.828 USD and a high forecast of 6.3 USD.

Lowest
Price Target
2.828 USD
306% Upside
Average
Price Target
4.488 USD
545% Upside
Highest
Price Target
6.3 USD
805% Upside
60 Degrees Pharmaceuticals Inc Competitors:
Price Targets
HROW
Harrow Health Inc
44% Upside
GUD
Knight Therapeutics Inc
34% Upside
4516
Nippon Shinyaku Co Ltd
0% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
37% Upside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
26% Upside
4521
Kaken Pharmaceutical Co Ltd
11% Upside
PFE
Pfizer Inc
17% Upside
CLN
Celon Pharma SA
35% Upside

Revenue
Forecast

Revenue Estimate
60 Degrees Pharmaceuticals Inc

For the last 3 years the compound annual growth rate for 60 Degrees Pharmaceuticals Inc's revenue is -52%. The projected CAGR for the next 4 years is 46%.

-52%
Past Growth
46%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
60 Degrees Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
60 Degrees Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SXTP's stock price target?
Price Target
4.488 USD

According to Wall Street analysts, the average 1-year price target for SXTP is 4.488 USD with a low forecast of 2.828 USD and a high forecast of 6.3 USD.

What is 60 Degrees Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
46%

For the last 3 years the compound annual growth rate for 60 Degrees Pharmaceuticals Inc's revenue is -52%. The projected CAGR for the next 4 years is 46%.

Back to Top